University of Florida Research Foundation Inc

Mead Johnson Nutrition Company

Mjn U.S. Holdings LLC

Josef Neu

Robert J McMahon

Maria B Grant

Udo Herz

William Michael Russell

Robert J Mcmahon

Mark A Atkinson

Graciela Liliana Lorca

Jui-Hong Chien

Desmond A Schatz

Eric Ortigoza

Eric W Triplett

Sungho Oh

Robert Mcmahon

An aspect of the invention described herein includes a method for a digestion diagnosis of a subject. The method includes obtaining electrogastrogram (EGG), bowel sound and NIRS signals from one or more sensors positioned about an abdominal region of a subject, removing artifacts from the signals to obtain conditioned signal data, and determining a digestion condition or feeding readiness of the subject based at least in part on the conditioned signal data.

Methods and systems for feeding readiness diagnosis

Isolatedstrains are useful in preventing or delaying the development of Type 1 Diabetes (T1D). A probiotic composition comprising thestrains and use of the composition in T1D prevention are provided.

[object Object]

The present disclosure is directed to a novel nutritional formula for treating or preventing systemic inflammation in a subject. The nutritional formula comprises a therapeutically effective amount of inactivatedGG (LGG).

Method for reducing or preventing systemic inflammation

A children's or infant's nutritional product utilizing or containing one or more inactivated probiotics for preventing or reducing systemic and/or respiratory inflammation in a child or infant.

Method for the utilization of and product containing inactivated probiotic

The subject invention provides compositions, and uses thereof, that improve gastrointestinal function. The compositions and methods of the subject invention are particularly advantageous for use with neonates because they can be used to stimulate development of the immature intestine in order to provide an enhanced ability to absorb nutrients and attain a stronger barrier function.

Formulation to improve gastrointestinal function

The subject invention provides dipeptides useful in promoting healthy muscle tissues as well as effective immune responses. The dipeptides of the subject invention are particularly advantageous because they are stable, bioavailable, and can be formulated in an aqueous solution.

Dipeptides for prevention of muscle breakdown and microbial infection

The subject invention provides dipeptides useful in preventing pathological proliferation of blood vessels. The dipeptides of the subject invention are particularly advantageous because they are stable, bioavailable, and can be formulated in an aqueous solution.

Growing community of inventors

Gainesville, FL, United States of America

Josef Neu